Stifel Foresees Upside In Shire (SHPG); HSBC Minimizes Financial Impact of SEC Probe on Alibaba Group (BABA)


Brokerage firm Stifel initiated coverage on Shire plc (Nasdaq:SHPG) stock with a Buy rating and a price target of $230.00, representing a more than 19% upside potential over its price at close on Wednesday of $191.78 per share

For the first quarter 2016, the global specialty pharmaceutical delivered double-digit year-over-year growth in product sales and Non GAAP earnings per American Depositary Share (ADS)

Shire, which researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products, has 197.23M Shares Outstanding, Market Capitalization (intraday) of $37.83B and SHPG stock 52-week range is between $147.60 and $270.63 per share



Shares of Alibaba Group Holding Ltd. (NYSE:BABA) closed Wednesday’s trading session in negative territory by 6.82% (or -$5.53) at $75.59 after the company disclosed in its annual filing that the U.S. Securities and Exchange Commission (SEC) is investigating its accounting practices.

HSBC analyst Chi Tsang told investors – in a research note – that the financial impact of the SEC investigation will be limited on the Chinese e-commerce giant. He also maintained a Buy rating on Alibaba’s stock with a price target of $113.00 per share

Alibaba posted fourth quarter fiscal 2016 revenue of RMB24,184 million ($3.75 billion) and non-GAAP net income of RMB7,635 million ($1.18 billion) for the period

Alibaba, which operates as an online and mobile commerce company in the People’s Republic of China and internationally, has 2.47B Shares Outstanding, Market Capitalization (intraday) of $186.71B and BABA stock one-year range is from $57.20 to $91.93 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at